Skip to contentTREU JESSE I — Somaxon Pharmaceuticals, Inc. insider: 566 transactions · InsiderLensTREU JESSE I
- 10% owner at IOMAI CORP · on record since Jan 25, 2006
- Director at Somaxon Pharmaceuticals, Inc. · on record since Feb 1, 2006
- 10% owner at Somaxon Pharmaceuticals, Inc. · on record since Feb 1, 2006
- 10% owner at SANTARUS INC · on record since Mar 31, 2004
- 10% owner at Volcano CORP · on record since Jun 20, 2006
- Director at VERACYTE, INC. · on record since Oct 29, 2013
- 10% owner at VERACYTE, INC. · on record since Oct 29, 2013
- 10% owner at Vanda Pharmaceuticals Inc. · on record since Apr 18, 2006
- 10% owner at NOVACEA INC · on record since May 16, 2006
- Director at Northstar Neuroscience, Inc. · on record since May 11, 2006
- 10% owner at Northstar Neuroscience, Inc. · on record since May 11, 2006
- 10% owner at CADENCE PHARMACEUTICALS INC · on record since Oct 30, 2006
- Director at SENORX INC · on record since Mar 28, 2007
- 10% owner at SENORX INC · on record since Mar 28, 2007
- 10% owner at Orexigen Therapeutics, Inc. · on record since Apr 25, 2007
- 10% owner at NUVASIVE INC · on record since May 12, 2004
- 10% owner at Clovis Oncology, Inc. · on record since Nov 21, 2011
- Director at INSPIRE PHARMACEUTICALS INC · on record since Jul 16, 2003
- 10% owner at ALIMERA SCIENCES INC · on record since Apr 27, 2010
- 10% owner at ACHILLION PHARMACEUTICALS INC · on record since Aug 23, 2010
- 10% owner at ZOGENIX, INC. · on record since Nov 22, 2010
- Director at Neutral Tandem Inc · on record since Nov 19, 2013
- 10% owner at Neutral Tandem Inc · on record since Nov 19, 2013
- 10% owner at REVA Medical, Inc. · on record since Dec 20, 2010
- 10% owner at SENOMYX INC · on record since Jun 17, 2004
- 10% owner at Durata Therapeutics, Inc. · on record since Jul 24, 2012
- 10% owner at Celator Pharmaceuticals Inc · on record since Jan 15, 2013
- 10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
- 10% owner at TRANZYME INC · on record since Jul 31, 2013
- 10% owner at Evoke Pharma Inc · on record since Sep 30, 2013
- Director at Regado Biosciences Inc · on record since Aug 28, 2013
- 10% owner at Regado Biosciences Inc · on record since Aug 28, 2013
- 10% owner at Dicerna Pharmaceuticals Inc · on record since Jan 29, 2014
- 10% owner at Achaogen Inc · on record since Mar 17, 2014
- Director at Aldeyra Therapeutics, Inc. · on record since May 7, 2014
- 10% owner at Aldeyra Therapeutics, Inc. · on record since May 7, 2014
- 10% owner at MARINUS PHARMACEUTICALS INC · on record since Jul 31, 2014
- 10% owner at Otonomy, Inc. · on record since Aug 18, 2014
- 10% owner at OBALON THERAPEUTICS INC · on record since Oct 14, 2016
- 10% owner at Neothetics, Inc. · on record since Nov 26, 2014
- 10% owner at Atara Biotherapeutics, Inc. · on record since Oct 21, 2014
- 10% owner at INTRALASE CORP · on record since Oct 6, 2004
- 10% owner at GLAUKOS Corp · on record since Jun 24, 2015
- 10% owner at Lifeline Systems, Inc. · on record since May 12, 2015
- Director at CoLucid Pharmaceuticals, Inc. · on record since May 11, 2015
- 10% owner at CoLucid Pharmaceuticals, Inc. · on record since May 11, 2015
- 10% owner at Syndax Pharmaceuticals Inc · on record since Mar 8, 2016
- 10% owner at Bionano Genomics, Inc. · on record since Aug 27, 2018
- 10% owner at HEPALIFE TECHNOLOGIES INC · on record since May 13, 2019
Insider trading activity of TREU JESSE I
- Transactions on record
- 566
- since Apr 8, 2004
- Open-market buys
- 65
- $114.3M
- Open-market sells
- 93
- $99.4M
- Companies traded
- 31
- last filing Jun 11, 2020
Figures computed from official regulatory filings — methodology.
Companies where TREU JESSE I has traded
- Aldeyra Therapeutics, Inc.17 tx · $968.4K · Jun 11, 2020
- VERACYTE, INC.27 tx · $26.9M · Mar 4, 2019
- OBALON THERAPEUTICS INC1 tx · $3M · Aug 27, 2018
- TRANZYME INC7 tx · $16M · Dec 13, 2017
- Neutral Tandem Inc16 tx · Nov 17, 2016
- Evoke Pharma Inc7 tx · $108.9K · Apr 27, 2016
- Lifeline Systems, Inc.4 tx · May 12, 2015
- CoLucid Pharmaceuticals, Inc.9 tx · $4M · May 11, 2015
- Esperion Therapeutics, Inc.11 tx · $4M · Mar 24, 2015
Track record of TREU JESSE I
Statistical track record
Free- Open-market buys
- 72
- Last buy
- Aug 23, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of TREU JESSE I
Co-insiders of TREU JESSE I
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
18 tx · $3M · Jan 5, 2015
Domain Partners VIII, L.P.Atara Biotherapeutics, Inc. +10
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 11, 2020 | AwardD | 26,503 | 0.00 USD | $0 | SEC |
| Jun 11, 2020 | AwardD | 2,465 | 0.00 USD | $0 | SEC |
| Jun 11, 2020 | AwardD | 2,311 | 0.00 USD | $0 | SEC |
| Jun 6, 2019 | AwardD | 1,653 | 0.00 USD | $0 | SEC |
| Jun 6, 2019 | AwardD | 1,763 | 0.00 USD | $0 | SEC |
| Jun 6, 2019 | AwardD | 18,951 | 0.00 USD | $0 | SEC |
| Mar 28, 2019 | Sell | -445 | 10.01 USD | $4.5K | SEC |
| Mar 28, 2019 | Sell | -96,298 | 10.01 USD | $963.9K | SEC |
| Mar 4, 2019 | Sell | -12,193 | 20.21 USD | $246.4K | SEC |
| Mar 4, 2019 | Sell | -272,977 | 20.45 USD | $5.6M | SEC |
| Mar 4, 2019 | Sell | -414,958 | 20.21 USD | $8.4M | SEC |
| Mar 4, 2019 | Sell | -2,381 | 20.44 USD | $48.7K | SEC |
| Mar 4, 2019 | Sell | -207 | 21.24 USD | $4.4K | SEC |
| Mar 4, 2019 | Sell | -2,023 | 20.45 USD | $41.4K | SEC |
| Mar 4, 2019 | Sell | -319,619 | 20.44 USD | $6.5M | SEC |
| Mar 4, 2019 | Sell | -27,793 | 21.24 USD | $590.3K | SEC |
| Aug 27, 2018 | Buy | 1,648,359 | 1.82 USD | $3M | SEC |
| Aug 2, 2018 | Sell | -119,112 | 10.85 USD | $1.3M | SEC |
| Aug 2, 2018 | Sell | -2,812 | 10.82 USD | $30.4K | SEC |
| Aug 2, 2018 | Sell | -888 | 10.85 USD | $9.6K | SEC |
| Aug 2, 2018 | Sell | -377,188 | 10.82 USD | $4.1M | SEC |
| Jun 11, 2018 | AwardD | 1,354 | 0.00 USD | $0 | SEC |
| Jun 11, 2018 | AwardD | 1,444 | 0.00 USD | $0 | SEC |
| Jun 11, 2018 | AwardD | 15,526 | 0.00 USD | $0 | SEC |
| Jun 8, 2018 | AwardD | 10,000 | 0.00 USD | $0 | SEC |